TP53 and serous adenocarcinoma: Unlike low-grade endometrioid carcinomas, which are often PTEN-driven and hormone-sensitive, serous carcinomas are characterized by p53 dysfunction and are typically estrogen receptor (ER) and progesterone receptor (PR) negative [41].